Human umbilical cord-derived mesenchymal stem cell therapy (Beijing Institute of Regenerative Biotech)

人脐带间充质干细胞（北京再生生物）

Report date: 2025/09/05 16:52:31

Base Information

Drug NameHuman umbilical cord-derived mesenchymal stem cell therapy (Beijing Institute of Regenerative Biotech)
Drug Alias NameBC-U001
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsErectile Dysfunction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Institute of Regenerative Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesBeijing Institute of Regenerative Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsErectile Dysfunction
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A